01 10Medrol
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 469
2018 Revenue in Millions : 493
Growth (%) : -5
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 402
2019 Revenue in Millions : 469
Growth (%) : -14
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 432
2020 Revenue in Millions : 402
Growth (%) : 7
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 328
2021 Revenue in Millions : 432
Growth (%) : -24
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 339
2022 Revenue in Millions : 328
Growth (%) : 3
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2014 Revenue in Millions : -4.50%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2015 Revenue in Millions : 381
2014 Revenue in Millions : 402
Growth (%) : 6%
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2016 Revenue in Millions : 450
2015 Revenue in Millions : 402
Growth (%) : 12
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2017 Revenue in Millions : 483
2016 Revenue in Millions : 450
Growth (%) : 7
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2018 Revenue in Millions : 426
2017 Revenue in Millions : 483
Growth (%) : -12%
LOOKING FOR A SUPPLIER?